Standard

Investment in child and adolescent health and development : key messages from Disease Control Priorities, 3rd Edition. / Disease Control Priorities-3 Child and Adolescent Health and Development Authors Group.

In: The Lancet, Vol. 391, No. 10121, 17.02.2018, p. 687-699.

Research output: Contribution to journal › Review article › peer-review

Harvard

Disease Control Priorities-3 Child and Adolescent Health and Development Authors Group 2018, 'Investment in child and adolescent health and development: key messages from Disease Control Priorities, 3rd Edition', The Lancet, vol. 391, no. 10121, pp. 687-699. https://doi.org/10.1016/S0140-6736(17)32417-0

APA

Disease Control Priorities-3 Child and Adolescent Health and Development Authors Group (2018). Investment in child and adolescent health and development: key messages from Disease Control Priorities, 3rd Edition. The Lancet, 391(10121), 687-699. https://doi.org/10.1016/S0140-6736(17)32417-0

Vancouver

Disease Control Priorities-3 Child and Adolescent Health and Development Authors Group. Investment in child and adolescent health and development: key messages from Disease Control Priorities, 3rd Edition. The Lancet. 2018 Feb 17;391(10121):687-699. https://doi.org/10.1016/S0140-6736(17)32417-0

Author

Disease Control Priorities-3 Child and Adolescent Health and Development Authors Group. / Investment in child and adolescent health and development : key messages from Disease Control Priorities, 3rd Edition. In: The Lancet. 2018 ; Vol. 391, No. 10121. pp. 687-699.

BibTeX

@article{25b4934879a24fc8835dc94140d459e6,
title = "Investment in child and adolescent health and development: key messages from Disease Control Priorities, 3rd Edition",
abstract = "The realisation of human potential for development requires age-specific investment throughout the 8000 days of childhood and adolescence. Focus on the first 1000 days is an essential but insufficient investment. Intervention is also required in three later phases: the middle childhood growth and consolidation phase (5–9 years), when infection and malnutrition constrain growth, and mortality is higher than previously recognised; the adolescent growth spurt (10–14 years), when substantial changes place commensurate demands on good diet and health; and the adolescent phase of growth and consolidation (15–19 years), when new responses are needed to support brain maturation, intense social engagement, and emotional control. Two cost-efficient packages, one delivered through schools and one focusing on later adolescence, would provide phase-specific support across the life cycle, securing the gains of investment in the first 1000 days, enabling substantial catch-up from early growth failure, and leveraging improved learning from concomitant education investments.",
author = "{Disease Control Priorities-3 Child and Adolescent Health and Development Authors Group} and Bundy, {Donald A.P.} and {de Silva}, Nilanthi and Susan Horton and Patton, {George C.} and Linda Schultz and Jamison, {Dean T.} and Amina Abubakara and Amrita Ahuja and Harold Alderman and Nicolas Allen and Laura Appleby and Elisabetta Aurino and Peter Azzopardi and Sarah Baird and Louise Banham and Jere Behrman and Habib Benzian and Sonia Bhalotra and Zulfiqar Bhutta and Maureen Black and Paul Bloem and Chris Bonell and Mark Bradley and Sally Brinkman and Simon Brooker and Carmen Burbano and Nicolas Burnett and Tania Cernuschi and Sian Clarke and Carolyn Coffey and Peter Colenso and Kevin Croke and Amy Daniels and {De la Cruz}, Elia and {de Walque}, Damien and Anil Deolaikar and Lesley Drake and Lia Fernald and Meena Fernandes and Deepika Fernando and G{\"u}nther Fink and Rae Galloway and Aulo Gelli and Andreas Georgiadis and Caroline Gitonga and Boitshepo Giyosa and Paul Glewwe and {Gona Nzovu}, Joseph and Amber Gove and Elena Grigorenko",
year = "2018",
month = feb,
day = "17",
doi = "10.1016/S0140-6736(17)32417-0",
language = "English",
volume = "391",
pages = "687--699",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier",
number = "10121",

}

RIS

TY - JOUR

T1 - Investment in child and adolescent health and development

T2 - key messages from Disease Control Priorities, 3rd Edition

AU - Disease Control Priorities-3 Child and Adolescent Health and Development Authors Group

AU - Bundy, Donald A.P.

AU - de Silva, Nilanthi

AU - Horton, Susan

AU - Patton, George C.

AU - Schultz, Linda

AU - Jamison, Dean T.

AU - Abubakara, Amina

AU - Ahuja, Amrita

AU - Alderman, Harold

AU - Allen, Nicolas

AU - Appleby, Laura

AU - Aurino, Elisabetta

AU - Azzopardi, Peter

AU - Baird, Sarah

AU - Banham, Louise

AU - Behrman, Jere

AU - Benzian, Habib

AU - Bhalotra, Sonia

AU - Bhutta, Zulfiqar

AU - Black, Maureen

AU - Bloem, Paul

AU - Bonell, Chris

AU - Bradley, Mark

AU - Brinkman, Sally

AU - Brooker, Simon

AU - Burbano, Carmen

AU - Burnett, Nicolas

AU - Cernuschi, Tania

AU - Clarke, Sian

AU - Coffey, Carolyn

AU - Colenso, Peter

AU - Croke, Kevin

AU - Daniels, Amy

AU - De la Cruz, Elia

AU - de Walque, Damien

AU - Deolaikar, Anil

AU - Drake, Lesley

AU - Fernald, Lia

AU - Fernandes, Meena

AU - Fernando, Deepika

AU - Fink, Günther

AU - Galloway, Rae

AU - Gelli, Aulo

AU - Georgiadis, Andreas

AU - Gitonga, Caroline

AU - Giyosa, Boitshepo

AU - Glewwe, Paul

AU - Gona Nzovu, Joseph

AU - Gove, Amber

AU - Grigorenko, Elena

PY - 2018/2/17

Y1 - 2018/2/17

N2 - The realisation of human potential for development requires age-specific investment throughout the 8000 days of childhood and adolescence. Focus on the first 1000 days is an essential but insufficient investment. Intervention is also required in three later phases: the middle childhood growth and consolidation phase (5–9 years), when infection and malnutrition constrain growth, and mortality is higher than previously recognised; the adolescent growth spurt (10–14 years), when substantial changes place commensurate demands on good diet and health; and the adolescent phase of growth and consolidation (15–19 years), when new responses are needed to support brain maturation, intense social engagement, and emotional control. Two cost-efficient packages, one delivered through schools and one focusing on later adolescence, would provide phase-specific support across the life cycle, securing the gains of investment in the first 1000 days, enabling substantial catch-up from early growth failure, and leveraging improved learning from concomitant education investments.

AB - The realisation of human potential for development requires age-specific investment throughout the 8000 days of childhood and adolescence. Focus on the first 1000 days is an essential but insufficient investment. Intervention is also required in three later phases: the middle childhood growth and consolidation phase (5–9 years), when infection and malnutrition constrain growth, and mortality is higher than previously recognised; the adolescent growth spurt (10–14 years), when substantial changes place commensurate demands on good diet and health; and the adolescent phase of growth and consolidation (15–19 years), when new responses are needed to support brain maturation, intense social engagement, and emotional control. Two cost-efficient packages, one delivered through schools and one focusing on later adolescence, would provide phase-specific support across the life cycle, securing the gains of investment in the first 1000 days, enabling substantial catch-up from early growth failure, and leveraging improved learning from concomitant education investments.

UR - http://www.scopus.com/inward/record.url?scp=85034088393&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(17)32417-0

DO - 10.1016/S0140-6736(17)32417-0

M3 - Review article

C2 - 29153316

AN - SCOPUS:85034088393

VL - 391

SP - 687

EP - 699

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 10121

ER -

ID: 62763036